CAPSAICIN

N/A

Manufactured by Averitas Pharma Inc

6,703 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CAPSAICIN

CAPSAICIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Averitas Pharma Inc. The most commonly reported adverse reactions for CAPSAICIN include APPLICATION SITE PAIN, PAIN, DRUG INEFFECTIVE, BURNING SENSATION, PAIN IN EXTREMITY. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CAPSAICIN.

Top Adverse Reactions

APPLICATION SITE PAIN476 reports
PAIN404 reports
DRUG INEFFECTIVE351 reports
BURNING SENSATION291 reports
PAIN IN EXTREMITY178 reports
FATIGUE162 reports
OFF LABEL USE141 reports
APPLICATION SITE ERYTHEMA138 reports
INSOMNIA101 reports
WEIGHT INCREASED100 reports
DYSPNOEA99 reports
NAUSEA91 reports
ERYTHEMA89 reports
PARAESTHESIA88 reports
HYPERTENSION85 reports
HYPOAESTHESIA82 reports
DIZZINESS78 reports
POOR QUALITY SLEEP76 reports
APPLICATION SITE BURN74 reports
HERPES ZOSTER74 reports
CATARACT70 reports
CONDITION AGGRAVATED70 reports
FALL69 reports
IMPAIRED QUALITY OF LIFE68 reports
IMPAIRED WORK ABILITY68 reports
CONTUSION67 reports
MALAISE66 reports
CELLULITIS64 reports
COUGH64 reports
PRURITUS64 reports
ARTHRALGIA63 reports
HYPERLIPIDAEMIA63 reports
BONE DENSITY DECREASED62 reports
CONFUSIONAL STATE61 reports
SKIN DISORDER61 reports
APPLICATION SITE VESICLES58 reports
FEELING HOT58 reports
BLISTER57 reports
BODY TINEA57 reports
DEATH57 reports
GLUCOSE TOLERANCE IMPAIRED57 reports
INFECTION SUSCEPTIBILITY INCREASED57 reports
ORAL HERPES57 reports
PURPURA57 reports
RASH56 reports
INHIBITORY DRUG INTERACTION53 reports
VOMITING53 reports
HEADACHE52 reports
HYPERSENSITIVITY52 reports
CONSTIPATION51 reports
DIARRHOEA50 reports
MUSCLE SPASMS50 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE50 reports
THERAPY NON RESPONDER48 reports
ASTHENIA45 reports
DRUG HYPERSENSITIVITY45 reports
ANXIETY43 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS43 reports
BURNS SECOND DEGREE42 reports
DEPRESSION41 reports
NEURALGIA41 reports
PERIPHERAL SWELLING41 reports
PNEUMONIA41 reports
PRODUCT USE ISSUE41 reports
CHEST PAIN40 reports
GAIT DISTURBANCE39 reports
OCCUPATIONAL EXPOSURE TO PRODUCT39 reports
BACK PAIN37 reports
ABDOMINAL PAIN UPPER35 reports
NEUROPATHY PERIPHERAL35 reports
PRODUCT USE IN UNAPPROVED INDICATION35 reports
MYALGIA34 reports
SKIN BURNING SENSATION34 reports
FEELING ABNORMAL33 reports
PYREXIA33 reports
SOMNOLENCE33 reports
DIABETIC NEUROPATHY31 reports
NASOPHARYNGITIS31 reports
THERMAL BURN31 reports
TREATMENT FAILURE31 reports
ACCIDENTAL EXPOSURE TO PRODUCT30 reports
ATRIAL FIBRILLATION30 reports
IMMUNE THROMBOCYTOPENIA30 reports
THROAT IRRITATION30 reports
APPLICATION SITE WARMTH29 reports
HYPOTENSION29 reports
DRUG INTERACTION28 reports
HYPERHIDROSIS28 reports
ABDOMINAL PAIN27 reports
OSTEOARTHRITIS27 reports
SLEEP DISORDER27 reports
TREMOR27 reports
PRODUCT QUALITY ISSUE26 reports
WEIGHT DECREASED26 reports
ACUTE KIDNEY INJURY25 reports
ANAPHYLACTIC REACTION25 reports
APPLICATION SITE SWELLING25 reports
EMOTIONAL DISTRESS25 reports
BLOOD CREATININE INCREASED24 reports
BLOOD PRESSURE INCREASED23 reports

Report Outcomes

Out of 3,031 classified reports for CAPSAICIN:

Serious 60.2%Non-Serious 39.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female1,581 (55.3%)
Male1,273 (44.5%)
Unknown7 (0.2%)

Reports by Age

Age 50104 reports
Age 6261 reports
Age 6160 reports
Age 6853 reports
Age 7153 reports
Age 5552 reports
Age 7552 reports
Age 7652 reports
Age 5750 reports
Age 6550 reports
Age 5849 reports
Age 6048 reports
Age 7245 reports
Age 6944 reports
Age 5243 reports
Age 6743 reports
Age 5640 reports
Age 7040 reports
Age 6439 reports
Age 5937 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CAPSAICIN?

This profile reflects 6,703 FDA FAERS reports that mention CAPSAICIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CAPSAICIN?

Frequently reported terms in FAERS include APPLICATION SITE PAIN, PAIN, DRUG INEFFECTIVE, BURNING SENSATION, PAIN IN EXTREMITY, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CAPSAICIN?

Labeling and FAERS entries often list Averitas Pharma Inc in connection with CAPSAICIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.